Evidence map›Paper›PMID 26607256›Full record

ReviewBrain research2016

Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.

David Weinshenker, Philip V Holmes

Open access · greenAbstract readReview
In one paragraph

Review in Brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 58 citations in OpenAlex.

  1. CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  2. Review
  3. Review
  4. Sex and life experience shape locus coeruleus pretangle tau pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Neuropeptides: The Evergreen Jack-of-All-Trades in Neuronal Circuit Development and Regulation.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. The neuropeptide landscape of human prefrontal cortex.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Review
  19. Co-released norepinephrine and galanin act on different timescales to promote stress-induced anxiety-like behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  20. Involvement of Scratch2 in GalR1-mediated depression-like behaviors in the rat ventral periaqueductal gray.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, 615 Michael St., Whitehead 301, Atlanta, GA 30322, USA. Electronic address: dweinshenker@genetics.emory.edu.
Philip V HolmesNeuroscience Program, Biomedical and Health Sciences Institute and Psychology Department, University of Georgia, Athens, GA 30602, USA. Electronic address: pvholmes@uga.edu.
Emory University · USUniversity of Georgia · US

Funding

Effects of voluntary exercise on reinstatement of cocaine seekingR01DA027535 · NIDA · EMORY UNIVERSITY · PI HOLMES, PHILIP V, WEINSHENKER, DAVID · 2010 to 2014
$1.9M
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition 5R01DA038453-02 Diversity SupplementR01DA038453 · NIDA · EMORY UNIVERSITY · PI PALADINI, CARLOS ANTONIO, WEINSHENKER, DAVID · 2015 to 2019
$1.8M
Consequences of Locus Coeruleus Activation in a Rat Model of Alzheimer's DiseaseRF1AG047667 · NIA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2014 to 2014
$1.7M
NIA NIH HHS RF1 AG047667NIDA NIH HHS R01 DA027535NIDA NIH HHS R01 DA038453
6 · The paper itself

Abstract

Decades of research confirm that noradrenergic locus coeruleus (LC) neurons are essential for arousal, attention, motivation, and stress responses. While most studies on LC transmission focused unsurprisingly on norepinephrine (NE), adrenergic signaling cannot account for all the consequences of LC activation. Galanin coexists with NE in the vast majority of LC neurons, yet the precise function of this neuropeptide has proved to be surprisingly elusive given our solid understanding of the LC system. To elucidate the contribution of galanin to LC physiology, here we briefly summarize the nature of stimuli that drive LC activity from a neuroanatomical perspective. We go on to describe the LC pathways in which galanin most likely exerts its effects on behavior, with a focus on addiction, depression, epilepsy, stress, and Alzheimer׳s disease. We propose a model in which LC-derived galanin has two distinct functions: as a neuromodulator, primarily acting via the galanin 1 receptor (GAL1), and as a trophic factor, primarily acting via galanin receptor 2 (GAL2). Finally, we discuss how the recent advances in neuropeptide detection, optogenetics and chemical genetics, and galanin receptor pharmacology can be harnessed to identify the roles of LC-derived galanin definitively. This article is part of a Special Issue entitled SI: Noradrenergic System.

Indexed as

AnimalsBehaviorGalaninHumansLocus CoeruleusNeural PathwaysNeuronsPhenotypeGalaninAddictionAlzheimer׳s diseaseDepressionEpilepsyGalaninLocus coeruleusNorepinephrineStress

Identifiers

PMID26607256
PMCPMC4874918
OpenAlexW2175268588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.